https://www.worldpharmatoday.com/clinical-trails/vertex-announces-positive-results-of-phase-2-study-of-nav1-8-inhibitor-vx-150-for-acute-pain/ Magazine for the C-level Pharma Executives Mon, 19 Feb 2018 06:23:11 +0000 hourly 1 https://wordpress.org/?v=6.9.4